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ABSTRACT 
 
According to recent British Heart Foundation statistics, one in six men and more than one in ten 
women die from coronary heart disease (CHD) in the UK. This equates to almost 74,000 deaths per 
annum from CHD alone.  More worryingly, every week, 12 apparently fit and healthy young people 
aged 35 and under, die from undiagnosed cardiac conditions. In both circumstances, monitoring is 
preformed only when triggered by an event. Unfortunately, this may be too late in the large majority 
of cases. For instance, there is evidence suggesting that most indiscernible cardiac abnormalities 
are made detectable by ECG through the act of suddenly standing upright. This infers that the 
condition would be detectable during the course of everyday ambulatory activity and highlights the 
need for a long term monitoring device. Current diagnostic equipment consists of the Holter monitor 
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for extended periods up to 36 hours and the implantable loop recorder (ILR) for monitoring up to 3 
years. The diagnostic yield of the ECG monitoring strategy is greatly increased as the monitoring 
period increases. Therefore, for subjects that exhibit symptoms of cardiac involvement that are 
transient in nature, the ILR offers the best opportunity for diagnosis. However, the ILR is inserted 
under the surface of the skin in the upper chest area and requires a surgical procedure, with 
associated risks, which makes ILR’s a costly and inconvenient option in many cases. 
The need for a non-invasive long term monitoring device, which is comfortable to wear along the 
arm and able to provide reliable ECG monitoring, has been addressed by many, in several lines of 
approach to a solution. This review details the current state of the art and any pending limitations. It 
then presents key multidisciplinary solutions on the different aspects of the problem, which will still 
require integration in order to realise such a device.  
 
 
Keywords: ECG; long term; monitor; arm worn; dysrhythmia. 
 
1. INTRODUCTION 
 
As heart disease remains a prevalent killer of 
both the old and the young [1], there is a strong 
case for the development of a long term 
monitoring technology that is non-invasive and 
comfortable to wear. Also, with recent research 
alluding toward an increased detectability of 
latent cardiac abnormalities once the subject 
stands from a seated position [2], the desirability 
and marketability of an arm worn sensor is 
increasingly realised [3].  
 
The effect of drugs on the heart rhythm is widely 
noted in the literature. An example being those 
which are linked with QT elongation or torsade 
de pointes.  Domperidone, for instance has been 
associated with a small increased risk of serious 
ventricular dysrhythmia or sudden cardiac death 
[4,5]. A warning strategy for patients continuously 
monitored during their course of treatment would 
significantly de-risk the administration period.  
 
Atrial fibrillation (AF) affects almost 800,000 
people in the UK, predominantly over 75 year 
olds with an affect rate of 10%. AF is uncommon 
in younger people; however, it may be 
coincidental with other heart defects such as 
heart valve problems [6]. Gauging the time a 
patient spends in paroxysmal atrial fibrillation will 
determine the treatment plan. Current analysis 
and recording equipment, such as the Omron 
HCG801 [7] (Fig. 1 (a)), do not give a good 
temporal picture because the recording is not 
continuous. The Holter monitor (Fig. 1 (b)) is a 
continuous data storage device; however, it is a 
short term technology, offering recording over 
time periods of 24hrs to 2 weeks. For longer 
recording periods, in the region of 28 days, an 
External Loop Recorder or Event Loop Recorder 
(ELR) may be selected by the clinician to act as 
a diagnostic tool. The ELR (Fig. 1 (c)) is available 
in two forms - permanently worn (looping 
memory) or as a post applied recorder (non-
looping memory). The permanently worn device 
may be automatically triggered by a threshold 
crossing of the patient’s heart rate or patient 
triggered once he has become aware of a 
dysrhythmia. The post event recorder is not worn 
continuously and as a result does not store any 
historical precursor to the dysrhythmic event. The 
post event recorder depends on the patient’s 
compliance with general operational protocols, 
the patient remaining sufficiently coherent to 
operate the event trigger and the maintenance of 
consciousness during the scope of the 
dysrhythmia. 
 
Real time monitoring of the cardiac output can be 
achieved using a fusion of ELR and cellular 
phone technology in the form of the Mobile 
Cardiac Output Telemetry recorder (MCOT) [8] 
(Fig. 1 (d)). MCOT recorders are a recent 
development and provide the wearer with a 24 hr 
full, high resolution data recording device. The 
device can provide the clinician with real time, 
streamed data over a cellular interface, hence 
delimiting the storage capacity. The technology 
may also be configured as a looping, non-
looping, event triggered and patient triggered 
device, capable of delivering a recording directly 
to the clinician. 
 
The Implantable Loop Recorder (ILR) overcomes 
patient noncompliance through surgical 
intervention. A small device, similar in size to a 
USB memory stick (Fig. 1 (e)), is implanted 
under the skin on the wall of the upper chest. 
The ILR is event triggered or can be patient 
triggered by placing an activator proximally on 
the chest. The more recent generations of this 
device are designed to operate in excess of 2 
years [9] and have wireless communication 
capability offering the provision of fast delivery of 
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data for interpretation and subsequent clinical 
decision.  
 
Thus, depending on the device time application, 
the available technology can operate in three 
time-range categories: limited to short term 
monitoring, up to 1 month, or very long term, in 
excess of 2 years. Without the risk and cost of 
the surgically implanted ILR, the middle category 
is not catered for. It is also notable that a 
continuous full data recording device is not yet 
available for periods over 1 month. 
 
Several key factors influence the success of a 
proposed very long term monitor. Firstly, the 
comfort of such a monitor is paramount. The 
ambulatory patient must be virtually unaware of 
the monitor’s presence to ensure that the urge to 
tamper with, or completely remove the device 
prematurely is mitigated. Several authors have 
suggested comfort sites for wearable electronics 
[10,11]. Gemperle et al. and Shackel et al. 
discuss the many factors that contribute to a 
subject feeling comfortable. Shackel discusses 
ergonomics of work place design, specifically 
chair comfort while Gemperle tested the design 
of wearable forms by studying subjects while 
they perform activities. Each subject rated the 
forms perceived comfort to allow the construction 
of a body position comfort model - shown in               
Fig. 2. 
 
 
 
 
Fig. 1. (a) Omoron HCG801 post applied non-looping recorder; (b) standard short term holter 
recording device; (c) Event Loop Recorder (ELR); (d) Mobile Cardiac Output Telemetry(MCOT); 
(e) Implantable Loop Recorder (ILR), standard and wirelessly enabled 
 
 
Fig. 2. Body sites for comfortable “wearability” (Gemperle et al.) [4] 
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Lynn (2013). concluded, by analysis of the data 
from a clinical study, that a significant reduction 
in ECG signal occurred on the right arm [12], an 
opinion supported by Hung-Chi Yang et al [13]. 
Hence all attempts at a successful arm worn 
device refer to data collected on the left limb. 
Yang developed a flexible foil electrode that can 
be conveniently wrapped around a limb and will 
facilitate the recording of ECG information –   
Fig. 3. He successfully extracted QRS 
information from the upper left arm (bicep region) 
and elbow position. However, attempts to 
recover ECG data from the wrist were 
unsuccessful. Yang has declared that the ECG 
signal at the wrist is “very weak” and is easily 
disrupted by electromyographic (EMG) noise. It 
is also notable that the signal processing used 
during his study was simplistic, consisting of 
bandwidth narrowing to remove power line and 
EMG noise. Yang’s chosen noise mitigation 
technique will have suppressed desired signal 
information ratio metrically with the noise 
component, as the frequency domain of the 
desired signal and the unwanted noise 
component are overlapped. The electrode design 
is of interest however. It is also probable that the 
recordings used in the Yang publication are best 
case selections and that a dry electrode, of the 
type described in the experiment, will produce 
large amounts of electrical noise should the 
subject move.  
 
1.1 The Noise Issue 
 
As is the case in most areas of measurement, 
the decisive boundary of detectability of a weak 
signal is determined by the presence of 
unwanted, random signals - or noise. Noise 
obscures the desired signal and poses a major 
challenge in the recovery of biological signals.  
 
The problem of noise is not limited to weak, low 
amplitude signals. The measurement accuracy 
and repeatability of comparatively large 
amplitude signals can also be affected by the 
presence of a noise component. When 
discussing the recovery of cardiac electrical 
activity, the signals can be described as low 
amplitude and low energy [14]. This means that 
the electrical signal produced by the heart is 
incapable of driving a low impedence load. The 
conditions described by physicist Georg Ohm, 
govern and predict the capability and behaviour 
of all measurement systems [15]. Consider     
Fig. 4; the component ZBM simulates the body 
impedance model, if the measurement system is 
‘ideal’ and has an input impedance of infinity, the 
maximum amplitude will be measured. If the 
measurement system impedance is equal to ZBM, 
the measured signal amplitude will appear to be 
50% of that measured from the ‘ideal’ system. 
The degradation continues as the input 
impedance of the measurement system 
decreases. In order to achieve a reasonable 
signal amplitude, a measurement system design 
with an input impedance of ZBM or greater is 
typically chosen. The trade-off being that the high 
impedance input also allows any noise 
component to be readily evident in the measured 
signal.
 
 
 
Fig. 3. Flexible printed circuit electrode trialled by Yang H et al. 2011. [7] 
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Fig. 4. Illustration showing measurement system interaction with the human body model 
impedance 
 
Noise falls into two main types - conducted and 
radiated. Conducted noise is that which is 
unavoidably present in the final signal. An 
example of which would be electromyographic 
disturbances. This type of noise can often be 
removed by signal averaging or bandwidth 
narrowing. Radiated noise is that which is 
propagated through the environment and 
electromagnetically coupled onto the bioamplifier 
high impedance input. Radio interference and 
mains (50Hz/60Hz) interference are examples of 
this. Radiated noise is often a function of 
physical layout of the system. Careful positioning 
of wires, electrodes and power cables can, along 
with filtering, reduce its affects. 
 
2. POTENTIAL SOLUTIONS 
 
2.1 Signal Denoising Techniques 
 
2.1.1 Signal averaging 
 
Signal averaging (SA) is a reasonably simplistic 
approach to noise removal from repetitive signals 
- the ECG, due to its rhythmic nature, is ideal for 
this approach. The technique requires a fiducial 
[16] or datum point to be identified. All 
subsequent repetitions of the signal are 
temporally aligned and the noise signals are 
expected to annihilate. The SA technique 
requires that the noise signals are non-coherent 
for successful filtering to take place. Power line 
interference and electromyographic noise 
sources, through their repetitive nature, often 
confound this technique.  
 
Temporal misalignment of the fiducial datum has 
the unwanted effect of integrating the output 
response, e.g. a pulse stream averaged and 
processed using an ideal, perfect temporal 
alignment will reproduce a perfect square pulse 
as an output. However if the fiducial point is 
subject to jitter, the output will be a smoothed 
pulse, ie the high frequency edges will have been 
lost. This phenomenon was discussed by 
Escalona et al [16] and William Craelius et al. 
[17]. Craelius also suggests that a temporal 
misalignment can add signal components to the 
filtered signal as well as subtract, producing false 
triggering of any beat extraction algorithm. A lot 
can be done to optimise the SA technique and 
reduce the levels of fiducial point jitter; however, 
a ‘real time’ beat to beat comparison is not 
achievable, therefore a successful clinical 
implementation of this technique is unlikely. 
 
2.1.2 Empirical mode decomposition 
 
Empirical Mode Decomposition (EMD) was 
developed by N. E. Huang [18] in 1998. EMD 
uses an iterative process to decompose a signal 
into a series of Intrinsic Mode Functions (IMF’s) 
subject to the following conditions. 
 
1)  In the whole data set the number of 
extreme and the number of zero crossings 
must be either equal or differ by, at most, 
one.  
2)  At any time the mean value of the 
envelope of the local maxima and the 
envelope of the local minima must equal 
zero. 
 
The IMF’s represent the oscillatory modes 
embedded in the signal x(t). Each IMF is actually 
a zero mean monocomponent AM-FM signal of 
the form x(t)=a(t)cosΦ(t). As most naturally 
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occurring signals contain more than one 
oscillatory mode they cannot be classed as 
IMF’s. The EMD process is designed to sift 
through the signal, breaking it down further with 
each pass, exposing the intrinsic oscillatory 
modes. The sifting process is defined by Zhao 
Zhidong et al. [19] as follows:- 
 
Find the local extrema and join the upper Xup(t) 
and lower envelopes Xlow(t) using a smooth 
cubic spline.  
 
Subtract the mean of the two envelopes m1(t) = 
((Xup(t) + Xlow(t))/2) to get their difference h1(t) 
= x(t)-m1(t). 
 
Repeat steps 1 and 2 until the signal h1(t) meets 
the criteria set out for an IMF - define as c1(t). 
The first IMF contains the highest frequency 
component of x(t). The residual r1(t) is given by 
r1(t)= x(t)-c1(t). 
 
Repeat steps 1,2 and 3 using r1(t) until all IMF’s 
have been extracted and rn(t) becomes 
monotonic.  
 
Simply, EMD decomposes a non-stationary 
signal into narrow band components with 
decreasing frequency. The original signal is 
defined as the summation of the IMF’s + rn(t) , 
therefore filtering is achieved by excluding the 
IMF containing the unwanted information prior to 
reconstruction by summation. 
 
A comparison of SA and EMD was presented by 
Lynn et al [20] and showed a promising, low 
latency method of rhythm artefact extraction from 
recordings recovered from the upper left arm.  
 
2.1.3 Ensemble empirical mode 
decomposition 
 
A major disadvantage of the classical EMD 
method is the mode-mixing effect. This becomes 
evident when pulsed high frequency components 
are mixed with a lower frequency constant wave. 
Again the ECG is an example of this type of 
signal, where the QRS complex is subject to 
base line drift caused by EMG or 50Hz mains. 
Mode mixing is said to occur when the IMF is not 
monotonic. This can be overcome by the use of 
the Ensemble Empirical Mode Decomposition 
(EEMD).  
 
The EEMD technique [21] overcomes the mode 
mixing problem by mixing white noise to the 
residual (rn(t)) before each resubmission to the 
IMF extraction algorithm. This has the effect of 
increasing the frequency of the splinic envelope 
and hence eliminating the aliasing effect which 
causes mode mixing. 
 
2.1.4 Wavelet analysis 
 
An alternative to EMD is the wavelet transform. A 
method referred to as wavelet transform 
thresholding is discussed by Alfaouri and 
Daqroug [22]. The thresholding method is similar 
to the EMD and EEMD technique, in that it uses 
the Discrete Wavelet Transform (DWT) to 
decompose the original into its wavelet series, 
then it passes the series through a threshold, 
which removes the coefficients below a certain 
value, before taking the inverse DWT. The 
mother wavelet suggested by Alfaouri et al is 
Daubechies DB4. However, a paper on a similar 
topic by Singh et al. [23] suggest using DB8. 
Singh provides evidence based proof for using 
DB8 and suggests that it produces least root 
mean square errors (RMSE) and also preserves 
the peaks of the ECG signal. Alfaouri’s work is 
directed at preserving the lower frequency 
aspects of the complex, the P wave and T wave. 
 
The work carried out by Alfaouri and Singh is 
directed at denoising and recovery of the ECG 
complex. Each work has a different agenda but 
has proved the DWT to be useful in extracting a 
detailed signal from noise. The technique 
compares the mother wavelet of choice in both 
time and scale across the data set and calculates 
a best fit with the data. This technique can also 
be used as a syntactic method of QRS detection, 
as described by M. Bahoura et al. [24]. 
Bahoura’s technique is an alternative to non-
syntactic methods such as the Pan-Tomkins [25] 
method. Non-syntactic techniques tend to suffer 
from two problems.  
 
1)  It has been found that the bandwidth of the 
QRS may alter between patients and in 
some cases the same patient at different 
times.  
2)  The bandwidth of the noise and the QRS 
overlap making filtering difficult. As 
mentioned earlier, this is especially 
problematic when mains noise at 50 or 60 
Hz is involved. Bahoura’s [24] proposed 
DWT technique is aimed at P and T wave 
extraction and has been tested on the MIT 
arrhythmia database. It was suggested that 
this tool could be used in the post 
processing of Holter recordings when 
assessing possible beat arrhythmias. 
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3. LOW NOISE SIGNAL ACQUISITION 
 
In order to record the ECG signal from remote 
regions of the body such as the forearm, wrist or 
thigh, an innovative, low noise signal recovery 
method will be required to support any signal 
processing technique. Failure to recover the 
desired signal is irreversible; no amount of post 
processing will facilitate extraction. 
 
A wrist worn device that will extract and monitor 
a clinical quality heart rate and or rhythm is 
described in US patent 4938228 [26], wrist worn 
heart rate monitor by William H. Righter et al. 
Righter, describes several of the essential 
features required by a wrist worn monitor in his 
patent.  
 
1)  The necessity for the device to be worn on 
an arm or leg, for example, rather than the 
chest area.  
2)  The requirement for the device to utilise a 
dry electrode arrangement for long term 
skin contact is highlighted  
3)  It is suggested that, in order to extract an 
adequate biometric signal, the acquisition 
should be in a differential mode.  
 
The Righter patent, although describing an ideal 
embodiment of the wrist worn clinical ECG 
monitor, disappoints by underachieving and 
details claims based around a monitor that 
requires the application of an oppositely 
polarised body part, ie the finger of the opposite 
hand. This creates a significantly large potential 
across the differential inputs, in the order of 1-2 
mV, while the ‘true’ wrist measured ECG is in the 
microvolts scale. Righter does not seem to 
mention the failing of this approach and 
continues to describe techniques to validate the 
detection of a QRS complex. His technique is 
based around maximum coherence matching of 
the real-time sampled data with a reference 
waveform. This technique requires that the data 
to be acted on is sufficiently filtered and free from 
noise [27]. 
 
Any design for a wrist worn monitor that is 
capable of continuous monitoring of an ECG 
signal will require analogue signal recovery to be 
carefully considered. For instance, typical clinical 
ECG recording equipment is a ‘single-ended’ 
recovery system, i.e. each channel is referred to 
a common point electrode, sometimes referred to 
as the CMS terminal. This means that the 
recovered signals are highly susceptible to 
common mode offset from the electrode potential 
and to environmental noise. The system also 
suffers greatly from crosstalk due to the both 
conducted and radiated noise. In a standard 
ECG, recording is not noticeably affected. 
However, when extracting a very low level ECG 
signal, about one thousand times smaller, from a 
similar noise environment, then crosstalk can 
becomes a major issue. A fully differential 
recovery would provide a solution to handle the 
effect of crosstalk.  
 
3.1 Biopotential Amplifiers Solutions 
 
Many texts describe the use of differential 
biopotential amplifiers. Nagel, J. H. [28] and 
Webster, J.G. [29] discuss the basic 
requirements of a biopotential amplifier and 
suggest that the minimum criteria are – 
 
The physiological process should not be 
influenced by the measurement process. 
The measured signal should be high fidelity 
The amplifier stage should offer high noise 
rejection  
 
The ‘standard’ amplifier type used to acquire 
biological signals is the differential or 
instrumentation amplifier. This is referenced in 
the majority of the literature surrounding the topic 
of instrumentation for biopotential acquisition. 
There are many variations on the topology from 
the standard differential conduction amplifiers to 
non-contact, high impedance amplifiers [30]. 
Wayne J. Smith et al describe a method of ECG 
recovery using an innovative, non-contact 
biopotential electrode. Their technique utilises an 
OPA129 FET op-amp from Burr-Brown in, what 
is essentially an open loop gain, differential input. 
A small portion of negative feedback has been 
applied to the non-inverting input via a 500 GΩ 
resistor to prevent the amplifier from saturating. 
Smith states that the circuit is a charge amplifier 
with an overall gain of 2 when the capacitively 
coupled electrode is about 5 mm from the body. 
Smith has quoted noise figures for his design in 
the order of 70uV/√Hz to 9.4uV/√Hz dependent 
of frequency. He has suggested an improvement 
may be made to the system noise figure by 
changing to an op-amp with a lower bias current 
and suggests the INA116 device. 
 
Smith’s method requires that the measurement 
system be referenced to the body by means of a 
contact electrode, therefore is not ideal for a wrist 
or arm located monitor. However, under some 
circumstances the technique may be adaptable 
to be of use. 
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Thomas J. Sullivan et al. [31] has developed an 
integrated sensor specifically for the purpose of 
EEG and ECG recovery in non-contact mode. 
Sullivan has used the INA116 device as 
suggested by Smith [31]. He has highlighted the 
areas where wet and dry contact electrodes can 
prove to be unreliable if used for long periods. It 
is also worth noting that both contact 
technologies are susceptible to variation in 
performance due to the wide range of skin types 
seen in application. This variation is evident 
across the relatively small sample size recorded 
in Lynn et al. (2013) clinical study [12], 
conducted at the Craigavon Area Hospital 
cardiac research facility.  
 
Sullivan has solved the referencing issue 
experienced by Smith by using an annular design 
electrode topology – Fig. 5. The central copper of 
the electrode layout is a capacitive sense 
element, as reported by Smith. The guarded 
output of the INA116 device is used to drive a 
guard ring that surrounds the central positive 
electrode. It is also used to drive a shielding layer 
that is displaced directly behind the capacitive 
electrode and overlapping the guard ring. The 
input current is extremely small, 3fA, but if left 
uncontrolled will eventually drive the INA116 into 
saturation. Smith combats this phenomenon by 
applying negative feedback. Sullivan has 
adopted a ‘short to ground’ approach through an 
NPN transistor, essentially a periodic reset of the 
input followed by a period of tolerable drift. 
 
Plessey Semiconductors [32] have developed 
the Sullivan and Smith approaches and are in the 
process of launching the EPIC electrostatic-
voltometer ASIC in the form of a non-contact 
ECG electrode. Plessey have also 
commercialised the EPIC technology as a wrist 
worn heart monitor [33] but have evidently run 
into problems of distal location and signal 
discrimination issues, as the product [34] 
requires the user to adopt the technique 
described in the Righter patent [26]. 
 
A further alternative to capacitive coupling to 
allow detection of the changes in the body’s 
electric field, is a proximal impedance 
spectroscopy technique described in the 
industrial patent Lynn et al. US0178902A1 [35]. 
Although the spirit of the patent is biased toward 
the industrial monitoring of carbon fibre 
composites, the technique may lend itself to be 
effective for the detection of small changes in the 
body’s electric field. Essentially, the system uses 
a plurality of transformer windings, displaced 
along a continuous ferrite core, to form a 
magnetic amplifier. The core is swept to 
determine its resonant frequency. The amplitude 
and frequency of the natural resonant frequency 
(F0) are indicative of the instantaneous shunt 
capacitance (Cp) and shunt resistance (Rp) of 
the proximal body. It is evident that this 
technique, although requiring substantial 
development, may also be capable of detecting 
an ECG without the requirement for a contact 
reference electrode. 
 
 
 
Fig. 5. Illustration showing annular ring electrode design cut from FR4 PCB material. (a) frontal 
elevation. (b) cross-section showing copper shielding layer 
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4. POWERING THE DEVICE 
 
A body worn device is ultimately required to have 
a low mass, a problem for long term monitoring. 
Traditional battery capacity is proportional to 
mass, as can be seen in Fig. 6 [36]. The 
portable, body worn device must have a long 
term operation window in excess of 4 weeks, it 
must also record and process continuously. All of 
which requires a significant power delivery 
capacity. Existing extended period monitoring 
technologies have circumvented this challenge 
by either reducing the period where the device is 
in full operation, by increasing the size of the 
battery or making the battery replaceable/ 
rechargeable.  
 
Periodic operation of the system is the usual 
industry technique for dealing with limited battery 
capacity. Devices such as implantable loop 
recorders and pacemakers run, the large majority 
of their life, in a semi-shutdown mode, only 
monitoring and processing the heart rhythm. The 
device is fully powered once an event is detected 
allowing the device to stay in use for 5 to 10 
years [37]. The act of writing to flash memory, 
delivering a pacing pulse or communicating via a 
radio frequency link is particularly power hungry 
and unsustainable for long periods with today’s 
battery technology. 
 
Industry, in particular Supervisory Control and 
Data Acquisition (SCADA) systems [38], has lead 
the way on techniques for supporting the limited 
battery life available for sensing technology. The 
use of energy harvesting is widespread however, 
a direct transfer of technology to the biomedical 
industry is not straight forward. The energy 
quotients used in industry and those wasted and 
therefore available for harvesting, are many 
scales of magnitude greater than those available 
from the human body. Techniques in kinetic 
energy harvesting from the body have already 
been commercialised [39,40]; though able to 
produce considerable energy, are not sufficiently 
compact or ergonomic to suit long term wearing. 
Other possibilities are solar [40] and 
thermoelectric [41], both attractive due to their 
robustness and high reliability. However, 
availability of direct light in sufficient quantities for 
solar operation, traded off against the physical 
size of the solar panel, is a significant problem. 
Thermoelectric energy harvested from the 
human body was first commercialised in the form 
of the Seiko Thermic wrist watch in 1998 [42]. It 
is possible to recover approximately 1 mW of the 
100W available from an adult at rest using 
today’s technology. Generation is dependent on 
a thermal gradient between the skin contact and 
the outer surface of the thermoelectric generator, 
an issue if the device is worn under clothing. 
 
 
Fig. 6. Battery capacity plotted against mass for the panasonic CR lithium manganese dioxide 
cell range 
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5. SUMMARY 
 
It is clear from the review that distal limb 
recovery of rhythm information is possible. Lynn 
[12] and Yang [13] have successfully recovered 
QRST ventricular electrical activity from the 
upper arm, showing that the signal is present, in 
some form, along the limb. Electrical noise is the 
confounding factor of recovery from the wrist, 
though it has been shown that the wrist may not 
be the most suitable place for a monitor of this 
type. A more stable platform may be the upper 
arm. That being the case, the techniques for 
successful recovery of rhythm information are in 
existence today. 
 
The importance of high quality signal recording 
has been made clear. Low noise, high 
impedence differential amplifiers are becoming 
common place in the electronics world. Their 
reliability is increasing and size and cost are 
decreasing, all driven by demand from other 
sectors, mainly mobile electronics. A reduction in 
physical size and over all power consumption, 
allows the construction of an extremely efficient, 
low noise device, which is ideal for use in a body-
worn monitor. 
 
Low noise recovery techniques deal with 
environmental and general system noise. The 
recovered signal is still subject to additionally 
recovered biological signals such as EMG. 
These are also considered to be ‘noise’, as they 
are unwanted in this particular application. The 
removal of such is made complex by the fact that 
the frequency domains of the desired signal and 
that of the noise overlap, a factor which 
precludes bandwidth narrowing as a sole method 
of filtering and post processing. A review of non-
syntactic algorithms showed that empirical mode 
decomposition and partial reconstruction can be 
used to improve the denoising of ECG signals 
recovered from the left arm. It is also worth 
noting that the syntactic approach, although 
successful has excessive latency and is 
therefore not suitable for dysrhythmia or complex 
morphology analysis in real time. 
 
As with all mobile technology the limitations are 
mainly from battery power sources. The possible 
implementation of an energy harvesting 
technique could increase the operation time and 
reduce the amount of patient interaction with the 
device, providing a more stable recording 
platform. 
 
6. CONCLUSION 
 
Cardiac disease is a prevalent killer in the 
modern world. More worryingly, the root cause of 
sudden cardiac death in the young often goes 
undiagnosed due to the inconvenience of the 
currently available long term monitoring 
solutions. The propositions mentioned herein 
describe the possibility of producing a non-
invasive long term monitor. The challenges 
presented are in the areas of positioning for 
comfort, electrode design, signal processing and 
power supply technology. All of which are 
discussed.  
 
It is evident from the literature the current 
technological capacity is such that developing a 
long term, non invasive continuous monitoring 
device is possible. 
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